期刊文献+

中枢神经系统弥漫大B细胞淋巴瘤相关microRNAs的研究进展 被引量:4

Research Progress on the microRNAs Related to the Diffuse Large B-cell Lymphoma of Central Nervous System
原文传递
导出
摘要 中枢神经系统(central nervous system,CNS)复发是弥漫大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)的一种不常见的严重的并发症,新诊断的患者2年内易于发生,最常见于非霍奇金淋巴瘤弥漫大B细胞型(non-Hodgkin diffuse large B-cell lymphoma-,NHL-DLBCL),目前,对于初始治疗后出现中枢复发其发病机制并不清楚。microRNA(miRNA)是一类新发现的非编码小分子RNA,通过抑制靶基因翻译或降解靶miRNA调控基因表达,参与细胞分化、增殖、调亡等生命活动。miRNA在淋巴瘤的发生发展中有重要作用。近年来大量研究已证实miRNA与肿瘤的组织来源、进展、转移预后与耐药都密切相关,既可作为抑癌基因,也可作为癌基因。淋巴瘤是一种血液免疫系统肿瘤,与淋巴瘤相关的miRNA已成为当前研究热点之一。microRNAs的功能紊乱如何导致DLBCL发生的机制目前还没有得到很好的证明,但DLBCL患者中464种miRNAs显示microRNA(包括miRNA-17-92簇)预测淋巴瘤的准确率达95%,为淋巴瘤研究提供了新依据。 Central nervous system(CNS) relapse is an uncommon devastating complication of diffuse large B-cell lymphoma(DLBCL) that usually occurs within 2 years from initial diagnosis. CNS relapse rates reported in series which contained mostly patients with diffuse large B-cell lymphoma(DLBCL), the most common non-Hodgkin lymphoma, however, in other aggressive lymphomas, the incidence of CNS relapse is low, ranging between 1 and 7%. There is no consensus on the definition of high-risk patients for CNS relapse. Micrornas(miRNA) is a new kind of non-coding small RNA molecules that inhibit or degradation of target miRNA and involve in cell differentiation, proliferation, apoptosis, and other life activities. Micrornas play an important role in the development of lymphoma.Micro RNA play an important role in the development of lymphoma. In recent years a large number of studies have identified correlation which microRNA, tumor tissue sources, progression, prognosis of metastasis and the resistance of drugs. It can be used as tumor suppressor genes, also as a cancer gene. Lymphoma which associated microRNA has become one of the current research hotspots is a kind of blood tumor immune system. The microRNAs of dysfunction mechanisms leading to DLBCL which has not been well proved,but 464 kinds of miRNAs in patients with DLBCL show miRNAs(including microRNAs- 17-92 clusters) prediction of the type of lymphoma accuracy reaches 95%, provides a new basis for the research of lymphoma.
出处 《现代生物医学进展》 CAS 2016年第2期390-392,396,共4页 Progress in Modern Biomedicine
基金 黑龙江省教育厅科学技术研究项目(12521179)
关键词 中枢神经系统 弥漫大B细胞淋巴瘤 MICRORNAS Central nervous system Diffuse large B-cell lymphoma MicroRNAs
  • 相关文献

参考文献31

  • 1Tali Siegal, Neta Goldschmidt. CNS prophylaxis in diffuse large B-cell lymphoma: If, when, how and for whom?[J]. Blood Reviews, 2012, 26:97-106.
  • 2Clozel T, Yang S, Elstrom RL, et al. Mechanism-based epigenetic them osensitization therapy of diffuse large B-cell lymphoma [J]. Cancer Diseov, 2013, 3(9): 1002-1019.
  • 3Claire Galand, Sabrina Dormou, Thierry Jo Molina, et al. Influence of tumor location on the composition of immune infiltrate and its impact on patient survival. Lessons from DCBCL and animal models [J]. Front lmmunol, 2012, 3:98.
  • 4Chang JE, Seo S, Kim KM et al.Rituximab and CHOP chemotherapy plus GM-CSF for previously untreated diffuse large B-cell lymphoma in the elderly: a Wisconsin ontology network study [J]. Clin Lyrnphoma Myeloma Leuk, 2010, 10(5): 379-384.
  • 5张晋琳.中枢神经系统淋巴瘤研究进展[J].实用医院临床杂志,2007,4(6):25-28. 被引量:4
  • 6Wei Ye, Liu Zhi-bin, Wang Li-chao, et al. Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances [J]. CNS Neuroscienee & Therapeutics, 2012, 8 (18): 609-615.
  • 7Roehle A, Hoeleg KP, Repsilber D, et al. MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lyrnphomas[J]. British Journal of Haematology, 2008, 142(5): 732.
  • 8刘棋,闫慧芝,温振科.miRNA与淋巴瘤发病机制的研究进展[J].中华肿瘤防治杂志,2011,18(23):1897-1900. 被引量:3
  • 9王晓薇.肿瘤细胞微环境对癌症转移力的影响[J].中州大学学报,2010,27(1):120-123. 被引量:1
  • 10吴颖颖,叶琇锦.微泡在肿瘤进展的作用及其临床应用[J].浙江大学学报(医学版),2012,41(1):105-110. 被引量:1

二级参考文献101

  • 1徐卫,李建勇,陆凤翔.微小RNA及其在恶性淋巴增殖性疾病中作用的研究进展[J].中国实验血液学杂志,2006,14(4):840-844. 被引量:4
  • 2[1]Gijtenbeek JM.Primary central nervous system T-cell lymphoma[J].Neu-rology,2001,57:716-718.
  • 3[2]Fred H,Joachim M.Primary CNS lymphoma[J].Nature,2007,3(1):24-35.
  • 4[3]Sacktor N.HIV-associated neurologic disease incidence changes:Multicenter AIDS Cohort Study[J].Neurology,2001,56:257-260.
  • 5[4]Smith JR.Expression of B-cell-attracting chemokine I (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma[J].Blood,2003,101:815-821.
  • 6[5]Jahnke K.Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes[J].J Clin Oncol,2006,24:4754-4757.
  • 7[6]Rubenstein JL.Gene expression and angiotropism in primary CNS lymphoma[J].Blood,2006,107:3716-3723.
  • 8[7]Alizadeh AA.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[J].Nature,2000,403:503-511.
  • 9[8]Moffat BA.Functional diffusion map:a noninvasive MRI biomarker for early stratification of clinical brain tumor response[J].Proc Natl Acad Sci USA,2005,102:5524-5529.
  • 10[9]Baehring JM.Analysis of clonal immunoglobulin heavy chain rearrangements in ocular lymphoma[J].Cancer,2005,104:591-597.

共引文献44

同被引文献20

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部